0001753939-19-000001.txt : 20190117 0001753939-19-000001.hdr.sgml : 20190117 20190117162605 ACCESSION NUMBER: 0001753939-19-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190115 FILED AS OF DATE: 20190117 DATE AS OF CHANGE: 20190117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Teague Robert Eric CENTRAL INDEX KEY: 0001753939 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-13789 FILM NUMBER: 19531206 MAIL ADDRESS: STREET 1: C/O MARINA BIOTECH, INC. STREET 2: 4721 EMPEROR BOULEVARD, SUITE 350 CITY: DURHAM STATE: NC ZIP: 27703 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adhera Therapeutics, Inc. CENTRAL INDEX KEY: 0000737207 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 112658569 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4721 EMPEROR BOULEVARD STREET 2: SUITE 350 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-578-5901 MAIL ADDRESS: STREET 1: 4721 EMPEROR BOULEVARD STREET 2: SUITE 350 CITY: DURHAM STATE: NC ZIP: 27703 FORMER COMPANY: FORMER CONFORMED NAME: Marina Biotech, Inc. DATE OF NAME CHANGE: 20100722 FORMER COMPANY: FORMER CONFORMED NAME: MDRNA, Inc. DATE OF NAME CHANGE: 20080610 FORMER COMPANY: FORMER CONFORMED NAME: NASTECH PHARMACEUTICAL CO INC DATE OF NAME CHANGE: 19920703 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2019-01-15 0 0000737207 Adhera Therapeutics, Inc. ATRX 0001753939 Teague Robert Eric C/O ADHERA THERAPEUTICS, INC. 4721 EMPEROR BOULEVARD, SUITE 350 DURHAM NC 27703 0 1 0 0 Chief Financial Officer Options to purchase common stock 0.32 2019-01-15 4 A 0 100000 0 A 2029-01-15 common stock 100000 100000 D Options to purchase 25,000 shares of common stock are exercisable immediately, and options to purchase 25,000 shares of common stock shall vest on each of the one, two and three year anniversaries of the grant date. /s/ R. Eric Teague 2019-01-17